Avidian Wealth Enterprises’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.1M Buy
46,029
+123
+0.3% +$38.4K 0.42% 41
2026
Q2
$19.9M Buy
45,906
+96
+0.2% +$29.1K 0.55% 35
2026
Q1
$9.8M Buy
45,810
+39,896
+675% +$8.92M 0.31% 55
2025
Q4
$1.01M Buy
5,914
+158
+3% +$24.6K 0.04% 221
2025
Q3
$771K Buy
5,756
+14
+0.2% +$1.48K 0.03% 268
2025
Q2
$559K Sell
5,742
-705
-11% -$55.9K 0.02% 309
2025
Q1
$469K Buy
6,447
+467
+8% +$36.8K 0.02% 317
2024
Q4
$432K Buy
+5,980
New +$454K 0.02% 323
2024
Q3
– Sell
-2,380
Closed -$254K – 518
2024
Q2
$254K Buy
+2,380
New +$228K 0.01% 426
2022
Q1
– Sell
-3,840
Closed -$276K – 546
2021
Q4
$276K Buy
+3,840
New +$241K 0.02% 421
2019
Q2
– Sell
-87,420
Closed -$1.56M – 157
2019
Q1
$1.56M Buy
+87,420
New +$1.46M 0.35% 31
2018
Q4
– Sell
-146,420
Closed -$2.22M – 108
2018
Q3
$2.22M Buy
+146,420
New +$2.5M 0.69% 20

Other funds holding LRCX

Avidian Wealth Enterprises's LRCX Position: Q3 2026 in Review

Avidian Wealth Enterprises increased its Lam Research (LRCX) stake by 0.27% in Q3 2026, buying an estimated $38.4K and bringing the position to 46,029 shares worth $15.1M. The position accounts for 0.42% of the portfolio, ranked #41.

Avidian Wealth Enterprises first reported a position in LRCX in Q3 2018 and has held it in 12 quarters since. The position peaked at $19.9M in Q2 2026. 2,587 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Avidian Wealth Enterprises held 46,029 shares of Lam Research worth $15.1M as of Q3 2026.
  • Avidian Wealth Enterprises bought 123 Lam Research shares in Q3 2026, an estimated $38.4K.
  • Lam Research made up 0.42% of Avidian Wealth Enterprises's portfolio in Q3 2026, its #41 holding.
  • Avidian Wealth Enterprises first reported a position in Lam Research in Q3 2018 and has held it in 12 quarters since.
  • Avidian Wealth Enterprises's Lam Research position peaked at $19.9M in Q2 2026.
  • 2,587 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q3 2026, filed 8 Oct 2026.